Literature DB >> 1760025

Problems with the two stage analysis of crossover trials.

S J Senn.   

Abstract

Mesh:

Year:  1991        PMID: 1760025      PMCID: PMC1368507          DOI: 10.1111/j.1365-2125.1991.tb05627.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

Authors:  J E GRIZZLE
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

2.  A graphical presentation of the results of crossover trials.

Authors:  T A Sheldon
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  The performance of the two-stage analysis of two-treatment, two-period crossover trials.

Authors:  P R Freeman
Journal:  Stat Med       Date:  1989-12       Impact factor: 2.373

4.  Cross-over trials, carry-over effects and the art of self-delusion.

Authors:  S J Senn
Journal:  Stat Med       Date:  1988-10       Impact factor: 2.373

5.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  5 in total
  3 in total

1.  Should we cross off the crossover?

Authors:  P Armitage
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 2.  Crossover studies are a better format for comparing equivalent treatments than parallel-group studies.

Authors:  T J Cleophas; E M de Vogel
Journal:  Pharm World Sci       Date:  1998-06

3.  A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.

Authors:  Chii-Dean Lin; Kung-Jong Lui
Journal:  Pharm Stat       Date:  2021-11-09       Impact factor: 1.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.